Skip to main content
Year archive

RESONANCE HEALTH LIMITED — 2021 filings

All 42 regulatory filings released by RESONANCE HEALTH LIMITED (RHT) in 2021, sourced directly from the official regulator.

42 Filings
2021 Period
2021 filings (42)
Filing Released Lang
US FDA Clearance for LiverSmart 6 pages 1.5MB
Capital/Financing Update
2021-12-29 English
ASO Project New Data 4 pages 579.3KB
Regulatory Filings
2021-12-19 English
LiverSmart Submitted to FDA for US Regulatory Clearance 2 pages 248.6KB
Regulatory Filings
2021-12-02 English
Jobkeeper Announcement 2 pages 145.4KB
Regulatory Filings
2021-11-28 English
Investor Presentation - Positioning for Growth 19 pages 2.7MB
Investor Presentation
2021-11-24 English
Results of Meeting 2 pages 157.1KB
Declaration of Voting Results & Voting Rights Announcements
2021-11-24 English
Appointment of CMO - Professor John Olynyk 3 pages 271.5KB
Board/Management Information
2021-11-23 English
ASO R&D Project - Filing of Two Patent Applications 3 pages 253.6KB
Regulatory Filings
2021-11-22 English
Thalassaemia International Federation to Deploy FerriSmart 3 pages 276.3KB
Regulatory Filings
2021-11-11 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 425.1KB
Interim / Quarterly Report Q1 2022
2021-10-28 English
Notice of Annual General Meeting/Proxy Form 20 pages 573.7KB
AGM Information
2021-10-24 English
Sales & Marketing Update 4 pages 286.6KB
Capital/Financing Update
2021-10-13 English
New AI Medical Device 3 pages 261.8KB
Regulatory Filings
2021-10-12 English
AGM Date and Director Nomination Closing Date 1 pag
AGM Information
2021-10-06 English
Annual Report to shareholders 61 pages 1.9MB
Annual Report FY 2021
2021-09-29 English
Appendix 4G and Corporate Governance Statement 16 pages 318.5KB
Governance Information
2021-09-29 English
Change in substantial holding 4 pages 98.3KB
Major Shareholding Notification
2021-09-27 English
R&D Molecular Medicine ASON Project Results of Dosing Study 2 pages 185.3KB
Regulatory Filings
2021-09-20 English
Preliminary Final Report 19 pages 502.7KB
Interim / Quarterly Report FY 2021
2021-08-29 English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 1.4MB
Interim / Quarterly Report Q4 2021
2021-08-01 English
Appointment of GM - Global Sales & Marketing 1 page
Board/Management Information
2021-07-27 English
Cancellation of Unlisted Options 1 page 83.4KB
Share Issue/Capital Change
2021-06-30 English
Change of Director's Interest Notice 3 pages 200.5KB
Director's Dealing
2021-06-30 English
Controlled Placement Facility - Extension and Increase 1
Capital/Financing Update
2021-06-29 English
Appointment of Managing Director 2 pages 265.7KB
Board/Management Information
2021-06-27 English
Change of Director's Interest Notice 3 pages 201.5KB
Director's Dealing
2021-06-27 English
Application for quotation of securities - RHT 6 pages 28.0KB
Share Issue/Capital Change
2021-06-10 English
Secondary Trading Notice 1 page 451.5KB
Regulatory Filings
2021-06-10 English
Resignation of CEO & Management Changes 2 pages 254.5KB
Board/Management Information
2021-06-03 English
Filing of Patent Application 3 pages 542.5KB
Regulatory Filings
2021-05-23 English
R&D Update - Molecular Medicine ASO Project 2 pages 254.8KB
Capital/Financing Update
2021-05-16 English
Appendix 4C - quarterly 9 pages 379.0KB
Interim / Quarterly Report Q3 2021
2021-04-28 English
Appointment of CFO & Company Secretary 1 page 214.6
Board/Management Information
2021-04-07 English
Secondary Trading Notice & Appendix 2A 16 pages 398.3KB
Capital/Financing Update
2021-03-08 English
Change of Director's Interest Notice 3 pages 588.9KB
Director's Dealing
2021-03-08 English
Half Yearly Report and Accounts 22 pages 1.1MB
Interim / Quarterly Report H1 2021
2021-02-25 English
HepaFat-AI receives CE Marking 4 pages 251.9KB
Regulatory Filings
2021-02-23 English
HepaFat-AI Receives TGA Approval 7 pages 279.9KB
Regulatory Filings
2021-02-17 English
Pause in Trading 1 page 111.8KB
Regulatory Filings
2021-02-16 English
Trading Halt 2 pages 584.9KB
Regulatory Filings
2021-02-16 English
Appendix 4C - quarterly 9 pages 408.2KB
Interim / Quarterly Report Q2 2021
2021-01-27 English
Secondary Trading Notice & Appendix 2A 16 pages 644.9KB
Regulatory Filings
2021-01-11 English